Safety and efficacy of NVX-CoV2373 Covid-19 vaccine PT Heath, EP Galiza, DN Baxter, M Boffito, D Browne, F Burns, ... New England Journal of Medicine 385 (13), 1172-1183, 2021 | 1114 | 2021 |
Long‐term follow‐up of 246 adults with juvenile idiopathic arthritis: functional outcome JC Packham, MA Hall Rheumatology 41 (12), 1428-1435, 2002 | 533 | 2002 |
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis GH Kingsley, A Kowalczyk, H Taylor, F Ibrahim, JC Packham, NJ McHugh, ... Rheumatology 51 (8), 1368-1377, 2012 | 450 | 2012 |
Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis A Deodhar, LS Gensler, J Sieper, M Clark, C Calderon, Y Wang, Y Zhou, ... Arthritis & Rheumatology 71 (2), 258-270, 2019 | 332 | 2019 |
Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis J Bowes, A Budu-Aggrey, U Huffmeier, S Uebe, K Steel, HL Hebert, ... Nature communications 6 (1), 6046, 2015 | 220 | 2015 |
Long‐term follow‐up of 246 adults with juvenile idiopathic arthritis: social function, relationships and sexual activity JC Packham, MA Hall Rheumatology 41 (12), 1440-1443, 2002 | 211 | 2002 |
Long‐term follow‐up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and pain JC Packham, MA Hall, TJ Pimm Rheumatology 41 (12), 1444-1449, 2002 | 189 | 2002 |
Long‐term follow‐up of 246 adults with juvenile idiopathic arthritis: education and employment JC Packham, MA Hall Rheumatology 41 (12), 1436-1439, 2002 | 185 | 2002 |
Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic SL Hider, W Tanveer, A Brownfield, DL Mattey, JC Packham Rheumatology 48 (9), 1152-1154, 2009 | 167 | 2009 |
Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies N Meader, AJ Mitchell, C Chew-Graham, D Goldberg, M Rizzo, V Bird, ... British Journal of General Practice 61 (593), e808-e820, 2011 | 159 | 2011 |
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer … S Toback, E Galiza, C Cosgrove, J Galloway, AL Goodman, PA Swift, ... The Lancet Respiratory Medicine 10 (2), 167-179, 2022 | 157 | 2022 |
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non … D Porter, J Van Melckebeke, J Dale, CM Messow, A McConnachie, ... The Lancet 388 (10041), 239-247, 2016 | 139 | 2016 |
Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis J Bowes, G Orozco, E Flynn, P Ho, R Brier, H Marzo-Ortega, L Coates, ... Annals of the rheumatic diseases 70 (9), 1641-1644, 2011 | 137 | 2011 |
Clinical utility of random anti–tumor necrosis factor drug–level testing and measurement of antidrug antibodies on the long‐term treatment response in rheumatoid arthritis M Jani, H Chinoy, RB Warren, CEM Griffiths, D Plant, B Fu, AW Morgan, ... Arthritis & rheumatology 67 (8), 2011-2019, 2015 | 118 | 2015 |
Impact of ankylosing spondylitis on work in patients across the UK EL Healey, KL Haywood, KP Jordan, A Garratt, JC Packham Scandinavian journal of rheumatology 40 (1), 34-40, 2011 | 112 | 2011 |
Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study W Tillett, G Shaddick, A Askari, A Cooper, P Creamer, G Clunie, ... Rheumatology 54 (1), 157-162, 2015 | 104 | 2015 |
Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis A Hinks, S Eyre, X Ke, A Barton, P Martin, E Flynn, J Packham, ... Annals of the rheumatic diseases 69 (6), 1049-1053, 2010 | 101 | 2010 |
Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis DL Mattey, JC Packham, NB Nixon, L Coates, P Creamer, S Hailwood, ... Arthritis research & therapy 14, 1-10, 2012 | 100 | 2012 |
Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris J Bowes, S Eyre, E Flynn, P Ho, S Salah, RB Warren, H Marzo-Ortega, ... Annals of the rheumatic diseases 70 (6), 1016-1019, 2011 | 100 | 2011 |
A multicenter, randomized, placebo‐controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis GD Kitas, P Nightingale, J Armitage, N Sattar, JJF Belch, DPM Symmons, ... Arthritis & rheumatology 71 (9), 1437-1449, 2019 | 98 | 2019 |